Elizabeth Yeu Lin, Chief Medical Officer: Tarsus Pharmaceuticals TARS Planned sale · Filed 09/04

Trade details

Type: Planned sale notice
Stock: Tarsus Pharmaceuticals TARS
Person: Elizabeth Yeu LinChief Medical Officer
Planned sale date: 26/09/04
Filed: 26/09/04

More to sell after $898K in 3 months

Tarsus Pharmaceuticals trades, last 26 weeks

What else happened in Tarsus Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 08/05~10/04

Elizabeth Yeu Lin's recent trades

Elizabeth Yeu LinChief Medical Officer
Planned sale10b5-1 planTarsus Pharmaceuticals
Planned sale10b5-1 plan
Tarsus Pharmaceuticals
TARS
$278.3K
3,180 sh
$278.3K
Filed 09/04
Traded 09/04
Elizabeth Yeu LinChief Medical Officer
Planned sale10b5-1 planTarsus Pharmaceuticals
Planned sale10b5-1 plan
Tarsus Pharmaceuticals
TARS
$127.2K
1,590 sh
$127.2K
Filed 09/02
Traded 09/02
Elizabeth Yeu LinChief Medical Officer
Planned sale10b5-1 planTarsus Pharmaceuticals
Planned sale10b5-1 plan
Tarsus Pharmaceuticals
TARS
$431K
5,387 sh
$431K
Filed 09/02
Traded 09/02
Elizabeth Yeu LinChief Medical Officer
Planned sale10b5-1 planTarsus Pharmaceuticals
Planned sale10b5-1 plan
Tarsus Pharmaceuticals
TARS
$339.8K
4,601 sh
$339.8K
Filed 09/01
Traded 09/01
Elizabeth Yeu LinChief Medical Officer
SellTarsus Pharmaceuticals
Sell
Tarsus Pharmaceuticals
TARS
$26.1K
390 sh
$26.1K
Filed 03/19
Traded 03/19